Researchers explored a colloidal crystal model to produce specific polymorphs, required for use in materials science and pharmaceuticals. Polymorphs are not mythical, chimeric beasts -- they are ...

Robert Millonig, Ph.D., Deepa Shiwcharan Pharm.D. Companies interested in researching, developing, and commercializing pharmaceutical compounds should be aware of not only strategies for patenting the ...

Gauging the adequate level and type of screening is the challenge when identifying relevant crystalline forms. Solid-dosage drugs remain the preferred dosage form due to ease of administration and ...

We were so pleased to have the opportunity to address InformaMarkets’ 13 th Annual Pharma IPR Conference in Mumbai on legal challenges to polymorph patents. Patents covering one or more crystalline ...

This is a preview. Log in through your library . Abstract Amyloid-β (Aβ) fibrils exhibit self-propagating, molecular-level polymorphisms that may contribute to variations in clinical and pathological ...

(a) Microscopic image and schematic representation of crystal polymorphs obtained via heteroepitaxial growth (α-phase: green; β-phase: red). Polystyrene particles with a diameter of 860 nm were used ...